Gene expression imputation provides insight into the genetic architecture of frontotemporal dementia
International FTD-Genomics Consortium (IFGC),
Yolande A.L. Pijnenburg,
Roel A Ophoff
Posted 23 Jun 2020
bioRxiv DOI: 10.1101/2020.06.23.166355
Posted 23 Jun 2020
The etiology of genetically sporadic frontotemporal dementia is poorly understood. Although genome-wide association studies for frontotemporal dementia have identified a small number of candidate risk regions, most of the risk genes remain largely unknown. To identify candidate genes with predicted expression levels associated with frontotemporal dementia, we integrated genome-wide summary statistics with external reference gene expression data, using a transcriptome-wide association studies approach. FUSION software was used to leverage summary statistics on frontotemporal dementia (n=2,340 cases, n=7,252 controls) and clinical subtypes (behavioral variant frontotemporal dementia n=1,337 cases/2,754 controls; semantic dementia n=308 cases/616 controls; progressive non-fluent aphasia n=269 cases/538 controls, frontotemporal dementia with motor neuron disease n=200 cases/400 controls) from the International Frontotemporal Dementia Genomics Consortium with 53 expression quantitative loci tissue type panels (n=12,205 from five consortia). Significance was assessed using a 5% false discovery rate threshold. We identified 73 significant gene-tissue associations for frontotemporal dementia, representing 44 unique genes in 34 tissue types. Most significant findings were derived from dorsolateral prefrontal cortex splicing data (n=19 genes, 26%). Furthermore, the 17q21.31 inversion locus contained 23 significant associations, representing six unique genes whose predicted expression associated with frontotemporal dementia. Other top hits included SEC22B on chromosome 1, a gene involved in vesicle trafficking, TRGV5 on chromosome 17 and ZNF302 on chromosome 19. A single gene finding was observed for behavioral variant frontotemporal dementia (i.e., RAB38 on chromosome 11) with evidence from multiple tissue types. For the other clinical subtypes no significant associations were observed. We used transcriptome-wide association studies to prioritize candidate genes for frontotemporal dementia and identified a number of specific genes, including potential novel candidate genes (such as SEC22B) and previously reported risk regions (e.g., 17q.21.31). Most significant associations were observed in the dorsolateral prefrontal cortex, despite the modest sample size of the gene expression reference panel of this tissue type. This suggests that our findings are specific to frontotemporal dementia and are likely to be biologically relevant highlights of genes at different frontotemporal dementia risk loci that are contributing to the disease pathology. ### Competing Interest Statement The authors have declared no competing interest.
- Downloaded 328 times
- Download rankings, all-time:
- Site-wide: 100,576
- In genetics: 4,217
- Year to date:
- Site-wide: 70,458
- Since beginning of last month:
- Site-wide: 64,469
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!